Investing

Goldman sees this biotech fighting rare diseases rallying 35%

The bank initiated coverage at a buy rating.

adminadmin
Sep 25, 2024 - 03:00
 0  26
Goldman sees this biotech fighting rare diseases rallying 35%
The bank initiated coverage at a buy rating.
Read More

Tags:

Previous Article

Here are Tuesday's biggest analyst calls: Nvidia, Apple, Walmart, Salesforce, St...

Next Article

The tax extension deadline is Oct. 15. Here's what to do if you still can't pay ...

admin
admin

Related Posts

How Apple's China suppliers could actually benefit from U.S. trade tensions, according to JPMorgan

How Apple's China suppliers could actually benefit from...

admin Oct 27, 2024  0  6

How to play the Fed decision using options on gold

How to play the Fed decision using options on gold

admin Sep 18, 2024  0  7

Apple just formed a bullish golden cross chart pattern

Apple just formed a bullish golden cross chart pattern

admin Jun 15, 2024  0  9